- Home
- MNPR vs CGC Comparison
MNPR vs CGC Comparison
Compare MNPR & CGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNPR
- CGC
- Stock Information
- Founded
- MNPR 2014
- CGC N/A
- Country
- MNPR United States
- CGC Canada
- Employees
- MNPR N/A
- CGC N/A
- Industry
- MNPR Biotechnology: Pharmaceutical Preparations
- CGC Pharmaceuticals and Biotechnology
- Sector
- MNPR Health Care
- CGC Health Care
- Exchange
- MNPR Nasdaq
- CGC Nasdaq
- Market Cap
- MNPR 209.3M
- CGC 239.2M
- IPO Year
- MNPR 2019
- CGC N/A
- Fundamental
- Price
- MNPR $44.97
- CGC $1.14
- Analyst Decision
- MNPR Strong Buy
- CGC Hold
- Analyst Count
- MNPR 7
- CGC 1
- Target Price
- MNPR $62.00
- CGC N/A
- AVG Volume (30 Days)
- MNPR 69.5K
- CGC 10.1M
- Earning Date
- MNPR 08-08-2025
- CGC 08-08-2025
- Dividend Yield
- MNPR N/A
- CGC N/A
- EPS Growth
- MNPR N/A
- CGC N/A
- EPS
- MNPR N/A
- CGC N/A
- Revenue
- MNPR N/A
- CGC $187,146,485.00
- Revenue This Year
- MNPR N/A
- CGC $11.99
- Revenue Next Year
- MNPR N/A
- CGC $6.84
- P/E Ratio
- MNPR N/A
- CGC N/A
- Revenue Growth
- MNPR N/A
- CGC N/A
- 52 Week Low
- MNPR $1.72
- CGC $0.77
- 52 Week High
- MNPR $54.30
- CGC $8.04
- Technical
- Relative Strength Index (RSI)
- MNPR 59.21
- CGC 45.22
- Support Level
- MNPR $44.26
- CGC $1.08
- Resistance Level
- MNPR $47.52
- CGC $1.27
- Average True Range (ATR)
- MNPR 3.49
- CGC 0.08
- MACD
- MNPR 0.54
- CGC 0.01
- Stochastic Oscillator
- MNPR 64.49
- CGC 26.92
About MNPR Monopar Therapeutics Inc.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.
About CGC Canopy Growth Corporation
Canopy Growth Corp, cultivates and sells medicinal and recreational cannabis and hemp through a portfolio of brands that include Doja, LivRelief, Ace Valley, Deep Space, and others. The Company is engaged in reportable segments namely: Canada cannabis, International markets cannabis, Storz & Bickel, and This Works. The company generates maximum revenue from Canadian cannabis.